Physician profile
Michael Salamon
NPI 1043218266
$4,872.08
in general payments reported to CMS, 2019-2025
12 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $44.43 · 2021: $119 · 2022: $423 · 2023: $2,725 · 2024: $535 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,725 · Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,725.00 |
| Food and Beverage | $930.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $2,968.25 | 2020-2024 | Aptus |
| Stryker Corporation | $758.70 | 2019-2025 | Inbone, Prophecy, Infinity Adaptis |
| Wright Medical Technology, INC. | $531.75 | 2019 | |
| Medline Industries Lp | $174.15 | 2024 | |
| Aap Implants INC | $106.16 | 2021 | |
| Depuy Synthes Sales INC. | $92.88 | 2022-2025 | Monovisc, Fms, Vapr |
| Medtronic, INC. | $74.27 | 2024 | Shilla Growth Guidance System |
| Treace Medical Concepts, INC. | $58.97 | 2024-2025 | |
| Blue Surgical LLC | $48.59 | 2024-2025 | |
| Smith+Nephew, INC. | $33.25 | 2024 | Q-Fix |
| Acumed LLC | $12.63 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Salamon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.